umich dsip Development Summer Internship Program Landing Page - Iris Registration

Key Takeaways CagriSema and Retatrutide are both investigational: Neither is FDA-approved for obesity or diabetes treatment as of May 2026

These include reduced nuclear factor-kappa B (NF-B) activation, decreased oxidative stress, and improved endothelial function

10.1186/s13018-019-1242-6 86 PetekM.SikiricP.AnicT.BuljatG.SeparovicJ.Stancic-RokotovD.et al (1999)

CAS 137525-51-0 MW 1419.53 g/mol Sequence Not listed Half-life Not listed Formula C62H98N16O22 Purity 99.65% Form Lyophilized powder Class Gastric Pentadecapeptide The dossier

Listed in the same Freeze Dried Isolates range and prepared from a lyophilised vial